Neurones (NRO) Financial Statements

5 Followers

Neurones Financial Overview

Neurones's market cap is currently €897.73M. The company's EPS TTM is €2.14; its P/E ratio is 6.68; and it has a dividend yield of 3.07%. Neurones is scheduled to report earnings on March 11, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 857.20M	€ 810.40M	€ 741.17M	€ 665.38M	€ 579.88M
Gross Profit	€ 90.04M	€ 388.76M	€ 346.76M	€ 81.64M	€ 69.73M
Operating Income	€ 72.33M	€ 77.90M	€ 75.86M	€ 72.89M	€ 61.57M
EBITDA	€ 90.32M	€ 85.92M	€ 96.63M	€ 88.72M	€ 76.23M
Net Income	€ 61.90M	€ 52.50M	€ 49.41M	€ 44.24M	€ 37.71M
Balance Sheet
Cash & Short-Term Investments	€ 340.78M	€ 326.49M	€ 297.76M	€ 272.06M	€ 265.17M
Total Assets	€ 749.03M	€ 725.69M	€ 674.25M	€ 616.22M	€ 567.82M
Total Debt	€ 36.96M	€ 42.02M	€ 43.98M	€ 35.57M	€ 35.32M
Net Debt	€ -303.82M	€ -284.47M	€ -253.78M	€ -236.49M	€ -229.85M
Total Liabilities	€ 284.16M	€ 289.52M	€ 266.34M	€ 240.63M	€ 214.90M
Stockholders' Equity	€ 399.98M	€ 378.10M	€ 354.39M	€ 330.58M	€ 311.56M
Cash Flow
Free Cash Flow	€ 70.33M	€ 72.34M	€ 54.09M	€ 44.33M	€ 58.10M
Operating Cash Flow	€ 80.77M	€ 84.38M	€ 72.08M	€ 54.94M	€ 64.68M
Investing Cash Flow	€ -21.16M	€ -19.69M	€ -21.57M	€ -12.26M	€ -10.62M
Financing Cash Flow	€ -45.11M	€ -34.48M	€ -27.06M	€ -36.08M	€ -55.42M

Currency in EUR

Neurones Earnings and Revenue History

Income Statement >

Neurones Debt to Assets

Balance Sheet >

Neurones Cash Flow

Cash Flow >

Neurones Forecast EPS vs Actual EPS

Earnings >